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Background
Thrombocytopenia is a common finding in several diseases but almost nothing is known about
the prevalence of thrombocytopenia in the general population. We examined the prevalence of
thrombocytopenia and determinants of platelet count in a healthy population with a wide age
range.
Design and Methods
We performed a cross-sectional study on 12,517 inhabitants of ten villages (80% of residents)
in a secluded area of Sardinia (Ogliastra). Participants underwent a complete blood count eval-
uation and a structured questionnaire, used to collect epidemiological data.
Results
We observed a platelet count lower than 150¥109/L in 3.2% (2.8%-3.6%) of females and 4.8%
(4.3%-5.4%) of males, with a value of 3.9% (3.6%-4.3%) in the entire population.
Thrombocytopenia was mild (platelet count: 100¥109/L -150¥109/L), asymptomatic and not
associated with other cytopenias or overt disorders in most cases. Its standardized prevalence
was quite different in different villages, with values ranging from 1.5% to 6.8%, and was neg-
atively correlated with the prevalence of a mild form of thrombocytosis, which ranged from
0.9% to 4.5%. Analysis of platelet counts across classes of age revealed that platelet number
decreased progressively with aging. As a consequence, thrombocytopenia was nearly absent in
young people and its prevalence increased regularly during lifetime. The opposite occurred for
thrombocytosis.
Conclusions
Given the high genetic differentiation among Ogliastra villages with “high” and “low” platelet
counts and the substantial heritability of this quantitative trait (54%), we concluded that the
propensity to present mild and transient thrombocytosis in youth and to acquire mild throm-
bocytopenia during aging are new genetic traits.
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Introduction
It is well known that thrombocytopenia is a common
finding in several illnesses and clinical conditions. For
instance, it has been shown that 46% of critically ill medical
and surgical patients have a platelet count lower than
150¥109/L,1 and that the prevalence of thrombocytopenia is
20% in patients with systemic lupus erythematosus,2 37%
in human immunodeficiency virus-positive drug users,3
18% in patients with chronic active hepatitis B, and 13% in
those with chronic hepatitis C.4
In contrast, almost nothing is known about the preva-
lence of thrombocytopenia in the general population,
although there is a general consensus that a low platelet
count is recognized with increasing frequency in apparently
healthy subjects, especially due to the measurement of
platelet numbers as part of routine blood testing.5,6 In some
of these cases, further clinical investigation reveals that
thrombocytopenia is secondary to an occult disease, while
in others it is found that the low platelet count is inherited.
When all known disorders are ruled out, subjects are usually
classified as affected by immune thrombocytopenia, since
no positive criteria have been identified for this disease and
its diagnosis remains one of exclusion.7
This study takes advantage of the availability of a data-
base including clinical, laboratory and genetic data of 12,517
subjects, resulting from a large population-based survey
performed in the Ogliastra region, Sardinia. This area is
characterized by genetic, demographic and environmental
features which are typical of founder populations and thus
ideal for studying genetic and non-genetic risk factors of
common diseases because of the reduced background vari-
ability.8,9 We addressed the issues of the prevalence of
thrombocytopenia and determinants of platelet count in a
healthy population with a wide age range. Although our
study analyzed a specific, small geographic area, the results
we obtained shed new light on some determinants of
platelet count that could also operate in other populations.
Design and Methods
Study design and data collection
We analyzed data from 12,517 inhabitants of the Ogliastra
region, in central eastern Sardinia, Italy (Figure 1). This mountain-
ous area is sparsely populated with a total of 60,000 inhabitants (34
inhabitants/km2) clustered in 23 villages. Ogliastra represents a
genetic isolate since it has been geographically and socially seclud-
ed for thousands of years due to the morphology of its territory.
Mitochondrial analysis traced the original population back to the
Neolithic era.10 Furthermore, several Ogliastra villages grew slowly
in isolation and had little or no admixture with the others, giving
rise to high endogamy (ranging from 70% to 90%) and inbreeding.
As a consequence of founder effects and genetic drift, a great deal
of genetic differentiation among subpopulation isolates within
Ogliastra was observed.11 Genetic diversity measures showed that
these villages rank among the most genetically homogenous
European populations.12
The data set comes from a large epidemiological survey carried
out in ten villages between 2002 and 2008. The study design was
cross-sectional and population-based. People living in the villages
were invited to take part in the study by means of information
campaigns and letters sent to every family, achieving a participa-
tion of about 80% of the resident population. The local adminis-
tration in each village provided a suitably equipped site where
respondents were invited to give fasting blood samples and under-
go an interview, after signing informed consent.
Trained personnel administered a structured questionnaire col-
lecting information on socio-demographic factors, lifestyle, drug
consumption as well as medical and family history of many
pathologies, including cancer, liver disorders, bleeding and throm-
botic events. Questions about present and past illnesses were all
asked  following the same fixed  schemes, for example, for liver
disease: “Have you ever had any liver disease (e.g., hepatitis, cir-
rhosis)? If yes, (since) when (year or age). Any relapse (number)?
Number and degree of affected relatives”. The disorders were clas-
sified according to the International Classification of Diseases, 9th
revision, Clinical Modification (ICD-9 CM13). Hematologic vari-
ables, including platelet, white blood cell and red blood cell counts,
mean corpuscular volume and hemoglobin concentration, were
determined by a Coulter LH Hematology analyzer (Beckman-
Coulter, Brea, CA, USA). Thrombocytopenia was defined as a
platelet count less than 150¥109/L, thrombocytosis as a platelet
count more than 400¥109/L, anemia as a hemoglobin concentration
less than 14.0 g/dL in men and 12.3 g/dL in women and leukopenia
as a white blood cell count less than 4¥109/L.
For each participant we collected genealogical information dat-
ing back to 17th century and stored them in a relational database
along with clinical and epidemiological data. To construct pedi-
grees we used a utility implemented in the PedNavigator soft-
ware,14 which allows the reconstruction of different types of
genealogies starting from a list of individuals and setting the
desired number of generations. Available data allowed us to organ-
ize the 12,517 enrolled people into 538 pedigrees (on average 4.6
generations deep) with an average family size of 37.7 individuals.
Sixty-four pedigrees had more than one member with a platelet
count lower than 150¥109/L. All of them were evaluated and clas-
sified into four groups according to the degree of relationship of
affected members: (i) at least three first- or second-degree throm-
bocytopenic relatives (high probability of a genetic disorder); (ii)
two first- or second-degree affected relatives (medium probability);
(iii) at least two third-degree affected relatives (low probability);
(iiii) no first- to third-degree affected relatives (no probability).
The study adhered to the tenets of the Declaration of Helsinki
and was approved by the review board of the institution that fund-
ed the research (Italian Ministry of Education, University and
Research n°: 5571/DSPAR/2002).
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Figure 1. Ogliastra region. Geographical location of the ten villages
participating in the epidemiological survey.
Statistical analysis
We explored the distribution of platelet counts in the whole
sample and by village. We next computed descriptive statistics
overall, by age and sex, and by village. T-tests and c2 tests were
used to assess differences of quantitative and dichotomous traits,
respectively, in men and women. Subsequently, we examined dif-
ferences in platelet counts among villages by analysis of variance
(ANOVA), adjusting for age and gender and using Bonferroni’s cor-
rection. Confidence intervals (CI) are at the 95% confidence level.
Prevalence rates of thrombocytopenia, thrombocytosis and disor-
ders that possibly cause secondary forms of these defects were
standardized by the direct method to the age and sex structure of
the 2008 Italy resident population.15 In order to identify potential
dominant or recessive transmission of thrombocytopenia, we
examined all the pedigrees including at least two affected individ-
uals. Finally, to quantify the relative genetic contribution to the
variation of platelet count, we carried out a heritability analysis
with the variance component method.16 This method partitions
the total phenotypic variance into genetic, shared environmental,
and individual-specific variances, and the heritability is simply
obtained as the ratio of genetic variance to the total phenotypic
variance. Since each village has a peculiar founder population and
may represent a genetic sub-isolate, separate heritability estimates
were obtained. STATA 9 software (StataCorp, College Station, TX,
USA) was used for all the analyses except for variance component
heritability analysis, which was performed using SOLAR software
(Sequential Oligogenic Linkage Analysis Routine, version 4.1.0).17
Results
Among the 12,517 subjects, 44.3% were men and 55.7%
women aged 3-105 years. Platelet count was higher in
women (P<0.0001), and the overall prevalence of thrombo-
cytopenia was 4.8% (95% CI, 4.3-5.4) in men and 3.2%
(95% CI, 2.8-3.6) in women, whereas the prevalence of
thrombocytosis was 1.5% (95% CI, 1.2-1.8) in men and 3%
(95% CI, 2.6-3.5) in women. The high prevalence of anemia
in our population is not surprising, since thalassemia trait is
widespread in Sardinia (12%) (Table 1).
Subjects were stratified into different groups according to
platelet count, and their distribution was markedly different
among villages (Table 2). This finding was confirmed by
ANOVA for platelet count after applying Bonferroni’s cor-
rection for multiple comparisons (α=0.0011) and taking into
account the effect of age and sex (Figure 2A). The standard-
ized prevalence of thrombocytopenia in the ten villages
ranged from 1.5% to 6.8%, whereas the prevalence of
thrombocytosis ranged from 0.9% to 4.5% (Online
Supplementary Figure S1). Based on these data, villages
seemed to cluster into three groups: (i) Talana and Urzulei,
(in northern inner Ogliastra) with the lowest platelet
counts, high prevalence of thrombocytopenia and low
prevalence of thrombocytosis; (ii) Seui, Seulo and Ussassai
(in western Ogliastra) with opposite findings; and (iii) the
remainder, located all around, with intermediate character-
istics. Differences between the polar opposite groups of vil-
lages in platelet counts and in the prevalences of thrombo-
cytopenia and thrombocytosis were statistically significant
(P<0.05). Densities of platelet counts in the three groups of
villages, even when adjusted for age and sex, give a graphi-
cal representation of all this matter (Figure 2B).
The distribution of platelet count by age and sex shows a
slow, progressive decline of platelet number with aging in
both males and females (Figure 3A). On average, a 10-year
increase in age corresponds to a 9¥109/L decrease in platelet
count, adjusting for sex (P<0.001). Consequently symmetri-
cal relationships of age with thrombocytopenia and throm-
bocytosis were evidenced in the overall sample (Figure 3B).
A strong, negative correlation between these two abnor-
malities was observed (Spearman’s rank correlation coeffi-
cient =-0.69, P=0.054). Similar findings were obtained when
these correlations were investigated in the three groups of
villages described above (Figure 3C).
We next estimated the standardized prevalence of the
clinical phenotypes possibly related to platelet counts in the
total sample and by village. Overall, we found that the
prevalence of liver disorders was 5.5% (95% CI, 5.1-5.9), of
cancer 2% (95% CI, 1.8-2.3), of bleeding events 0.8% (95%
CI, 0.6-0.9) and of thrombotic events 5.8% (95% CI, 5.4-
6.2). Furthermore, since the prevalence of thalassemia carri-
ers in Sardinia is about 12%, we specifically estimated the
prevalence of carriership in Ogliastra and found it to be
12.8% (95% CI, 12.2-13.3). Sporadic, significantly different
prevalences of the investigated diseases among the ten vil-
lages were identified, but they were not responsible for the
observed differences in the prevalence of thrombocytope-
nia or thrombocytosis (data not shown).
Heritability estimates for platelets count, adjusting for age
and sex (P<0.001), varied from 40% (Seui) to 53%
G. Biino et al.
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Table 1. Characteristics§ of the study population by sex.
                                                                         Men                         Women
                                                                       (5,540)                      (6,977)
Age** (mean ± SD), years                                       43.8±21.4                        45.7±20.9
Platelet count** ¥109/L (mean ± SD)                 240.5 (65.3)                    260.3 (67.5)
Number of subjects with:                                                                                            
thrombocytopenia**, n (%)                                  271 (4.9)                         234 (3.3)
thrombocytosis**, n (%)                                        87 (1.6)                          196 (2.8)
anemia**, n (%)                                                     1401 (25.3)                     1280 (18.3)
leukopenia** (%)                                                    104 (1.9)                         242 (3.5)
liver disorders, n (%)                                              299 (6.2)                         380 (6.1)
cancer*, n (%)                                                           95 (1.9)                          162 (2.6)
bleeding events, n (%)                                            41 (0.8)                           51 (0.8)
thrombotic events**, n (%)                                  358 (7.4)                         360 (5.7)
§data expressed as percentages are crude prevalences; *P<0.05, **P<0.0001 for t-test and c2 test
in men and women.
Table 2. Distribution (%) of subjects according to platelet counts (x109/L) in
the whole sample and by village.
Platelets 50-100 100-150 150-400 400-500 500-1000
(x109/L)<50
Talana 0.26 0.6 6.13 92.15 0.86 0
Urzulei 0.35 0.7 5.55 92.52 0.7 0.18
Triei 0.19 0.87 4.14 92.59 1.92 0.29
Baunei 0.29 0.96 2.76 94.02 1.67 0.29
Loceri 0.28 1.13 2.73 93.61 1.97 0.28
Perdasdefogu 0.33 0.33 2.57 94.8 1.75 0.22
Escalaplano 0.23 0.53 2.52 94.05 1.83 0.84
Seui 0 0.5 1.9 94.04 3.31 0.25
Seulo 0 0.22 1.31 94.74 3.07 0.66
Ussassai 0 0.85 1.28 93.38 4.27 0.21
Overall 0.22 0.67 3.14 93.7 1.94 0.32
(Ussassai). They were not significantly different among vil-
lages, so that we also carried out a further analysis pooling
together pedigrees of all the villages, obtaining a global her-
itability of 54% (95% CI, 49.7%-58.3%). Family environ-
mental factors shared during cohabitation accounted for
5% of phenotypic variance.
The study of family trees is summarized in Table 3.
Although thrombocytopenia affected more than one first-
to third-degree relatives in several families, in none of these
families did we identify a pattern of inheritance consistent
with the known forms of inherited thrombocytopenia.
Online Supplementary Figure S2 shows a representative pedi-
gree in which an autosomal dominant transmission may be
suspected in one branch of the family, but this hypothesis
was ruled out in other branches in which parents of throm-
bocytopenic subjects have normal platelet counts.
Discussion
To estimate the prevalence of thrombocytopenia for the
first time in the general population, we analyzed platelet
counts in 12,517 inhabitants of the Ogliastra region of
Sardinia, Italy, and obtained a value of 3.9%, with males
more frequently affected than females. Thrombocytopenia
was not associated with other cytopenias and was mild in
most cases. These data confirm the general sensation that,
after the introduction of cell counters that made platelet
counting a routine test, identification of patients with asymp-
tomatic thrombocytopenia became a common event.
A surprising characteristic of the Ogliastra population was
the great variation in the prevalence of thrombocytopenia
among different villages, with values ranging from 1.5% in
Seulo to 6.8% in Talana (Online Supplementary Figure S1).
Since each of these communities represents a geographic iso-
late within the larger Ogliastra isolate, we first hypothesized
that mutations responsible for one or more of the classical
forms of inherited thrombocytopenia were differently dif-
fused in these populations. However, the study of family
trees failed to show dominant or recessive transmission of
thrombocytopenia in any pedigree (Online Supplementary
Figure S2). Moreover, the analysis of the prevalence of throm-
bocytopenia in different classes of age (Figure 3B) identified a
direct and strong correlation between these two parameters,
with only 0.8% of people younger than 18 years having a low
platelet count. Since thrombocytopenia is congenital in all
known inherited forms, this finding ruled out the initial
hypothesis.
We next examined the possibility that differences in the
prevalence of this defect derived from unequal distribution of
cancer and liver disorders among different villages, since
these conditions are the most frequent causes of secondary
thrombocytopenia. Appropriate statistical analysis refuted
this hypothesis too (data not shown).
Finally, a possible explanation for the uneven distribution
of thrombocytopenia came from the analysis of platelet
counts in single communities. This parameter was roughly
normally distributed in all villages, but the curves were shift-
ed to the left in the populations with a higher prevalence of
thrombocytopenia, and to the right in those with few cases
of thrombocytopenia (Figure 2B). Since the collection of
blood samples took several years, we examined the possibil-
ity that seasonal variations in  platelet counts were responsi-
ble for the observed differences, but we excluded this possi-
bility (data not shown). Interestingly, the prevalence of throm-
bocytopenia was inversely related to that of thrombocytosis,
which affected 7.3% of subjects younger than 18 years and
0.9% of those older than 64 years. As a whole, these data sug-
gested that the "normal range" of platelet count was different
in each village, likely influenced by genetic factors, and that
the prevalence of thrombocytopenia derived from the inter-
action of this genetic trait with the propensity of platelet
number to decline with aging: in villages with higher “normal
Novel genetic traits underlying platelet counts
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Figure 2. (A) Platelet count in Ogliastra villages. Mean values are
age- and sex-adjusted by ANOVA, (95% C.I.). (A) Age- and sex-adjust-
ed platelet count densities in Ogliastra. Relative densities are plot-
ted grouping villages as follows: Talana and Urzulei, (northern inner
Ogliastra), Seui, Seulo and Ussassai (western Ogliastra), Baunei,
Loceri, Perdasdefogu, Escalaplano and Triei (remainder). 
Table 3. Pedigrees with more than one thrombocytopenic member
classified according to the degree of relationship of affected relatives.
                     ≥ 3 I-II degree*  2 I-II degree*     2 III degree*       Total
                            affected          affected             affected      pedigrees
                                 relatives             relatives              relatives
Talana                            2                           1                                0                       76
Urzulei                          4                           3                                0                       45
Triei                               2                           2                                0                       24
Baunei                           2                           4                                2                      117
Loceri                            1                           1                                0                       33
Perdasdefogu              0                           5                                0                       66
Escalaplano                  1                           2                                0                       68
Seui                                0                           0                                0                       44
Seulo                             0                           1                                0                       43
Ussassai                       0                           0                                1                       22
Overall                         12                         19                               3                      538







































































































ranges”, many young people have transient thrombocytosis
and few develop thrombocytopenia with aging, while in
communities with lower "normal ranges" the prevalence of
thrombocytosis in youth is low and many subjects acquire
thrombocytopenia during adult life.
Since it has been shown in different populations that
platelet count is highly heritable,18-20 we examined this matter
in Ogliastra, confirming the datum. Notably, previous analy-
ses on population structure through high density single
nucleotide polymorphisms revealed significant genetic het-
erogeneity among groups of Ogliastra villages, with the
largest difference being between Talana and Seulo (which
also show the largest difference in mean platelet count) and
the smallest difference between Baunei and Triei.21
Furthermore, the study of the distribution of 43 serological
and hematologic quantitative traits on the same cohort
showed that villages clustered accordingly.22 Northern inner
Ogliastra villages differ from western ones not only from a
genetic point of view, but also as far as platelet count is con-
cerned. Altogether these data further support the idea that the
propensity to present transient thrombocytosis in youth and
to acquire thrombocytopenia with aging are genetically trans-
mitted in the communities analyzed.
Further investigation is required to ascertain whether this
conclusion also applies to populations other than those living
in Ogliastra, but some evidence in the literature seems to sup-
port this hypothesis, at least concerning thrombocytopenia.
Several years ago, a wide variation of "normal" platelet counts
was identified in volunteers of different ethnic origins, such
that it was concluded that platelet counts well below
150¥109/L may be observed in healthy subjects of African and
Afro-Caribbean origin.23 This finding was subsequently con-
firmed by other researchers in a healthy Ugandan popula-
tion.24 Interestingly, platelet counts were significantly lower in
adults older than 24 years than among younger people.
Moreover, a recent study further supported the possibility
that mild thrombocytopenia does not necessarily imply an
underlying illness. After monitoring 191 healthy Italian adults
with incidentally discovered platelet counts between
100¥109/L and 150¥109/L for 64 months, it was concluded
that most of them did not develop either a platelet count
lower than 100¥109/L or any other disorder.25
Thus, the present investigation corroborates the conclu-
sions of previous studies and suggests that some subjects
inherit a predisposition to develop mild, “idiopathic” throm-
bocytopenia during adult life. At this point, an important
question is whether this type of thrombocytopenia should be
considered a new form of inherited thrombocytopenia with a
very low penetrance and late onset, or whether it represents
the lower extreme of the normal range of platelet count. The
best way to answer this question is to verify whether affected
subjects have a clinical phenotype related to their subnormal
platelet counts. We, therefore, searched for a relationship
between bleeding and thrombocytopenia in the whole popu-
lation, and concluded that no association existed. Moreover,
we found a similar prevalence of hemorrhages in people with
platelet counts between 50¥109/L and 150¥109/L (1.3%) and
those with platelet counts between 150¥109/L and 400¥109/L
(0.8%). At variance, bleeding events occurred more frequent-
ly (3.7%) in the few subjects with platelet counts lower than
50¥109/L. On this basis, it seems reasonable to conclude that
the mild thrombocytopenia affecting adults in the Ogliastra
area should not be considered an illness.
As for thrombocytopenia, the prevalence of thrombocyto-
sis in general population has never been reported in literature.
Thus our study provided the first estimate. The 2.3% preva-
lence we estimated looks surprisingly high, but thrombocyto-
sis was very mild in the vast majority of cases, with only
0.3% of subjects having a platelet count above 500¥109/L and
none having a count more than 1000¥109/L. We have no data
to identify for sure the origin of high platelet counts in
Ogliastra villages, but the declining prevalence of this abnor-
mality with age seems to exclude myeloproliferative disor-
ders. Since the frequency of thrombocytosis was significantly
different in different villages and was negatively related to
that of thrombocytopenia, the previous discussion on throm-
bocytopenia also applies to thrombocytosis and suggests that
the predisposition to this defect was inherited. Whether
genetic factors alone were sufficient to produce platelet
counts higher than normal or whether additional causes, such
G. Biino et al.
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Figure 3. (A) Platelet count by age and sex. Mean platelet count,
with 1 SD, in the overall sample. (B) Relationship of thrombocytope-
nia and thrombocytosis with age. Sex-adjusted age-specific preva-
lence of thrombocytopenia and thrombocytosis in the overall sam-
ple. (C) Relationship of thrombocytopenia and thrombocytosis with
age by groups of villages. Proportions along with standard errors,
are plotted grouping villages as follows: Talana and Urzulei, (north-
ern inner Ogliastra), Seui, Seulo and Ussassai (western Ogliastra),
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as inflammatory disorders, were required to uncover this
propensity is unknown to us, since the Ogliastra database
does not include parameters for answering this question. As
for thrombocytopenia, it is also important to decide whether
thrombocytosis is associated with a clinical phenotype. The
observation that thrombotic events were no more frequent in
populations with a higher prevalence of thrombocytosis
seems to indicate the benign nature of this defect. The finding
that none of the 107 subjects with thrombocytosis younger
than 18 years developed thrombosis further supports this
conclusion. Thus, the mild and transient thrombocytosis
affecting young Ogliastra people should not be considered an
illness, but rather the highest part of the normal range of
platelet count in this population.
From a practical point of view, the results of our study
show that an acquired, mild thrombocytopenia does not nec-
essarily indicate the presence of an underlying disorder. Thus,
after exclusion of causes of secondary thrombocytopenia and
demonstration that thrombocytopenia remains stable over
time, affected subjects can be reassured that, in all probability,
they are healthy and will not develop severe thrombocytope-
nia or suffer from bleeding events in the future.
Similar considerations also apply to young subjects with
mild thrombocytosis and no signs of myeloproliferative dis-
orders or any other illness: they do not risk thrombosis and,
in all probability, their platelet count will return within the
normal range in the future.
In other words, the usual normal range of platelet counts is
too narrow for the Ogliastra population and exposes people
to the risk of being investigated for illnesses that they do not
have. Further research is required to ascertain whether the
same concept also applies to populations other than the one
which we investigated. In this case, considering the possibil-
ity that a mild deviation from the normal range of platelet
count derives from the genetic background rather than from
an illness will become a general recommendation.
In conclusion, analysis of platelet counts in the Ogliastra
isolates provided the first estimate of the prevalence of
thrombocytopenia and thrombocytosis in a general popula-
tion, confirmed that platelet count is a highly heritable trait
and revealed that platelet number declines with aging.
Moreover, it revealed that the propensity to present platelet
counts slightly higher than 400¥109/L or lower than
150¥109/L is a new genetic trait.
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